Valens AH 2.0

Description

Valens™ AH 2.0 is a high-performance aluminum hydroxide adjuvant specifically engineered for human vaccine applications. Features optimized 2% aluminum oxide (Al2O3) content for enhanced immunogenicity. Characterized by positive surface charge enabling efficient adsorption of negatively charged antigens through strong electrostatic interactions. Advanced manufacturing process creates fine, uniform particle size distribution with narrow pH range for consistent performance. Enhanced protein adsorption capacity significantly improves antigen binding compared to standard aluminum hydroxide adjuvants.

Compatible with other vaccine components to stimulate additional immune pathways beyond standard Th2 responses. Enhances antibody-mediated immune responses while maintaining excellent safety profile. Manufactured under sterilized, scalable, cGMP-compliant production meeting both Ph.Eur and USP standards. Available in flexible packaging formats and volumes to accommodate various vaccine program scales from clinical trials to commercial production. Represents next generation of aluminum adjuvant technology with over 20 years SPI Pharma vaccine adjuvant expertise.